Telehealth & Compliance Notice A prescription is required for this program Approval is not guaranteed Payment does not ensure medication will be issued Compounded medications are not FDA-reviewed like commercial drugs This platform facilitates access to care but does not replace traditional medical services when needed

BPC-157: Best overall for joint pain Why it's #1 for joints: Reduces joint inflammation dramatically Promotes cartilage healing and regeneration Improves synovial fluid quality Works on all joints (knees, shoulders, hips, elbows) Proven track record for joint issues Best for: Osteoarthritis (wear-and-tear) Post-injury joint pain Chronic joint inflammation Multiple joints affected Any age (works for 20s to 70s+) Dosing for joint pain: 250-500mcg twice daily injectable Inject near painful joint for targeted relief Or systemic (abdomen) for multiple joints 8-16 weeks minimum Can use long-term safely Expected timeline: Week 2-4: Initial pain reduction Week 4-8: Significant improvement Week 8-16: Major pain relief, improved function Ongoing use maintains benefits Real results: 40-60% pain reduction typical Improved range of motion Less morning stiffness Better quality of life Use our BPC-157 dosage calculator and see our BPC-157 complete guide and how to take BPC-157

Sufficient B12 levels contribute to skin repair and regeneration, strengthen nails, and promote hair health, improving overall appearance and vitality
The Bigger Picture This advisory committee meeting is part of a broader and ongoing effort by FDA to impose order on the compounding landscape, particularly with respect to peptides and biologics that have grown popular in wellness, sports medicine, longevity, and integrative health settings
Hospira's labeling is explicit: Store at 2025C before opening
AOD 9604 is a synthetic fragment of human growth hormone, specifically amino acids 176 through 191 of the hGH sequence, with a single modification at the N-terminus for stability